Veradermics, Incorporated
Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the de… Read more
Veradermics, Incorporated (MANE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.066x
Based on the latest financial reports, Veradermics, Incorporated (MANE) has a cash flow conversion efficiency ratio of -0.066x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.63 Million) by net assets ($54.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Veradermics, Incorporated - Cash Flow Conversion Efficiency Trend (2023–2024)
This chart illustrates how Veradermics, Incorporated's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Veradermics, Incorporated Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Veradermics, Incorporated ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Toys"R"Us ANZ Limited
PINK:TOYRF
|
0.426x |
|
MOELIS & COMPANY (A)
BE:17M
|
0.364x |
|
CoinShares Physical Ethereum (ETH)
XETRA:CETH
|
N/A |
|
Rockworth Public Company Limited
BK:ROCK
|
0.109x |
|
STNLY BLCK&DECK
BE:SWF
|
0.032x |
|
FINMECCANICA - Dusseldorf Stock Exchang
DU:FMNB
|
0.046x |
|
E79 Resources Corp
OTCQB:ESVNF
|
-0.060x |
|
Earthwise Minerals Corp.
F:966
|
0.105x |
Annual Cash Flow Conversion Efficiency for Veradermics, Incorporated (2023–2024)
The table below shows the annual cash flow conversion efficiency of Veradermics, Incorporated from 2023 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $54.66 Million | $-23.69 Million | -0.433x | +53.11% |
| 2023-12-31 | $14.62 Million | $-13.51 Million | -0.924x | -- |